Axsome Therapeutics Financial Overview
Axsome Therapeutics's market cap is currently $7.70B. The company's EPS TTM is $-0.94; its P/E ratio is -33.10; Axsome Therapeutics is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $-0.72. See an overview of income statement, balance sheet, and cash flow financials.
